Lilly and T1D Exchange Announce Research Collaboration to Inform Development of New Initiatives to Advance Diabetes Care

BOSTON and INDIANAPOLIS, April 24, 2014 /PRNewswire/ — T1D Exchange and Eli
Lilly and Company (NYSE: LLY) announced today they have entered into a research
collaboration that will enable both organizations to gain deeper, real-world
insight about the experience of people with type 1 diabetes, to identify new
ways to improve care and advance outcomes.

As part of this multi-year collaboration, the organizations will engage in a
range of projects that combine Lilly’s long history of and expertise in type 1
diabetes with T1D Exchange’s innovative, patient-centric model that connects a
clinic registry of more than 26,000 people with T1D, a clinic network comprised
of more than 70 clinics across the U.S., a sample repository that stores patient
biosamples and Glu, a patient and caregiver online community for T1D. The
collaboration will involve multiple projects over an initial five-year period.

“Lilly’s commitment to supporting people with type 1 diabetes dates back to
1923, when we introduced the first commercially available insulin,” said Dara
Schuster, M.D., Medical Fellow, Lilly Diabetes. “Having access to the resources
of T1D Exchange to bolster our understanding of the needs of people with type 1
diabetes, their caregivers and health care providers will help us continue our
mission of addressing the global diabetes burden through the development of
innovative medicines and programs.”

The first project of the collaboration will assess user experience associated
with insulin pumps and multiple daily injections. Initially, T1D Exchange data
will be analyzed to inform development of a survey of health care providers from
the clinic network and members of the Glu community. Following the survey, a
study of clinic registry participants is planned, to further shed light on how
insulin pumps are used and how multiple daily injections occur in real-world
practice. Data and recommendations from this research will be shared publicly
once analysis is complete, for the benefit of both the type 1 diabetes and
researcher communities.

“The T1D Exchange Clinic Registry was established to provide real-world data on
a large number of children and adults with type 1 diabetes to serve as a
resource for both academic and company researchers,” said Dr. Roy Beck,
Director, T1D Exchange Clinic Coordinating Center, Executive Director, JAEB
Center for Health Research. “This collaboration with Lilly is a great example of
how the registry data can be used to address key issues that are important to
individuals with type 1 diabetes.”

About T1D Exchange
T1D Exchange, the first program of Unitio, was founded on the premise that
finding faster, better therapies for type 1 diabetes (T1D) requires a research
model as multi-faceted as the disease itself. T1D Exchange acts as a convener of
the thousands of people working to improve patient outcomes already–by
connecting them to one another and to the patient community at large. Drawing on
decades of research and data that have come before, T1D Exchange aims to be the
translational engine that enables the entire T1D ecosystem to collaborate in
truly novel ways via the integration of a Clinic Network, Clinic Registry,
Sample Repository, and the online patient/caregiver community, Glu. For more
information, please visit unitio.org/pages/t1d-exchange.

About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to make
life better for people around the world. We were founded more than a century ago
by a man committed to creating high-quality medicines that meet real needs, and
today we remain true to that mission in all our work. Across the globe, Lilly
employees work to discover and bring life-changing medicines to those who need
them, improve the understanding and management of disease, and give back to
communities through philanthropy and volunteerism. To learn more about Lilly,
please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels.

C-LLY

FOR MORE INFORMATION CONTACT:

Tracy McMahon
T1D Exchange
617.892.6143
tmcmahon@t1dexchange.org

Julie Williams
Eli Lilly and Company
317.627.4056
williams_julie_herrick@lilly.com

http://photos.prnewswire.com/prnvar/20031219/LLYLOGO

http://photos.prnewswire.com/prnvar/20140409/DE99887LOGO

Logo – http://photos.prnewswire.com/prnh/20031219/LLYLOGO
Photo – http://photos.prnewswire.com/prnh/20140409/DE99887LOGO

SOURCE Eli Lilly and Company

Leave a Reply


Fatal error: Call to undefined function show_subscription_checkbox() in /home3/steer/public_html/indianapressreleases.com/wp-content/themes/comfy/comments.php on line 95